Pangenomic Health Inc.
NARA
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.45M | -1.31M | -2.89M | -2.77M | -2.57M |
| Total Depreciation and Amortization | 400.00 | 1.80K | 4.00K | 6.20K | 8.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 611.80K | 183.10K | 1.88M | 1.82M | 1.78M |
| Change in Net Operating Assets | 606.20K | 974.70K | 917.00K | 898.30K | 507.50K |
| Cash from Operations | -1.23M | -155.20K | -83.50K | -41.80K | -271.40K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 187.50K | 187.50K | 47.00K | 47.00K | 385.00K |
| Total Debt Repaid | -187.50K | -62.50K | -- | -- | 110.90K |
| Issuance of Common Stock | 1.75M | 88.60K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -107.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.70K | -4.30K | 44.30K | 0.00 | -1.70K |
| Cash from Financing | 1.27M | 150.10K | 65.20K | 34.30K | 283.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.60K | -5.10K | -18.30K | -7.50K | 12.50K |